Kalium Health, a medtech start-up backed by Kidney Research UK to develop the world’s first blood potassium rapid self-test, is now...

We are pleased to have recently completed a collaboration with the University of Cambridge's Judge Business School.

Healthtech attracts investment because companies in this space offer excellent long-term financial returns by creating value for society

Martlet Capital is a Cambridge-based, early stage investor and one of our earliest backers. In this short Q&A series, we asked Peter...

Our decision to prioritise US market entry is based on the huge market opportunity and our world-class capabilities

How can partnerships improve healthcare? Article by our CEO Tom Collings, as published in European Pharmaceutical Manufacturer

Having recently announced the formation of our advisory board we wanted to take some time to introduce its initial members.

24 October 2023 Cambridge, UK Kalium Health, a Cambridge University spinout developing the world’s first blood potassium rapid self-test,...

Our short history has already been punctuated with several prestigious awards and nominations...

Kalium Health was delighted to participate in Cambridge Unlocked, an internship program designed to enable students from minorities and...

Kalium Health has been shortlisted in the Best Early Stage MedTech Company category of the 2023 OBN Awards

At Kalium Health our desire to forge impactful partnerships means we look for other companies working in the cardiorenal space...